These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 23530300)

  • 1. ACE inhibitor and ARB medication use among Medicaid enrollees with diabetes.
    Lora CM; Sokolovsky AW; Touchette DR; Jin J; Hu X; Gao W; Gerber BS
    Ethn Dis; 2013; 23(2):189-95. PubMed ID: 23530300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship Between Medication Adherence and Distance to Dispensing Pharmacies and Prescribers Among an Urban Medicaid Population with Diabetes Mellitus.
    Syed ST; Sharp LK; Kim Y; Jentleson A; Lora CM; Touchette DR; Berbaum ML; Suda KJ; Gerber BS
    Pharmacotherapy; 2016 Jun; 36(6):590-7. PubMed ID: 27087250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accepting Medication Therapy Management Recommendations to Add ACEIs or ARBs in Diabetes Care.
    Hurwitz JT; Grizzle AJ; Augustine J; Rehfeld R; Wild A; Abraham I
    J Manag Care Spec Pharm; 2016 Jan; 22(1):40-8. PubMed ID: 27015050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-risk diabetic patients in Medicare Part D programs: are they getting the recommended ACEI/ARB therapy?
    Yang Y; Thumula V; Pace PF; Banahan BF; Wilkin NE; Lobb WB
    J Gen Intern Med; 2010 Apr; 25(4):298-304. PubMed ID: 20108127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physician conformity and patient adherence to ACE inhibitors and ARBs in patients with diabetes, with and without renal disease and hypertension, in a medicaid managed care organization.
    Cooke CE; Fatodu H
    J Manag Care Pharm; 2006 Oct; 12(8):649-55. PubMed ID: 17269843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescription drug benefits and use of guideline recommended medications by elderly Medicare beneficiaries with diabetes mellitus.
    Tjia J; Briesacher BA
    J Am Geriatr Soc; 2008 Oct; 56(10):1879-86. PubMed ID: 18771456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating prescription of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in patients with diabetes and albuminuria.
    Chienwichai K; Chaloemwa P; Sangkaew S; Chang A
    Clin Nephrol; 2024 Jun; 101(6):277-286. PubMed ID: 38606848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Motivational Interviewing Intervention to Improve Adherence to ACEIs/ARBs among Nonadherent Older Adults with Comorbid Hypertension and Diabetes.
    Mohan A; Majd Z; Johnson ML; Essien EJ; Barner J; Serna O; Gallardo E; Fleming ML; Ordonez N; Holstad MM; Abughosh SM
    Drugs Aging; 2023 Apr; 40(4):377-390. PubMed ID: 36847995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual renin-angiotensin-aldosterone blockade: Implementation of published research and Dear Doctor letters in ambulatory care: A retrospective observational study using prescription data.
    Angelow A; Ploner T; Grimmsmann T; Walker J; Chenot JF
    Pharmacoepidemiol Drug Saf; 2020 May; 29(5):530-537. PubMed ID: 32162407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Pharmacist Telephone Intervention to Identify Adherence Barriers and Improve Adherence Among Nonadherent Patients with Comorbid Hypertension and Diabetes in a Medicare Advantage Plan.
    Abughosh SM; Wang X; Serna O; Henges C; Masilamani S; Essien EJ; Chung N; Fleming M
    J Manag Care Spec Pharm; 2016 Jan; 22(1):63-73. PubMed ID: 27015053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonadherence to angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers among high-risk patients with diabetes in Medicare Part D programs.
    Yang Y; Thumula V; Pace PF; Banahan BF; Wilkin NE; Lobb WB
    J Am Pharm Assoc (2003); 2010; 50(4):527-31. PubMed ID: 20621872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EVALUATING THE PRESCRIPTION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS OR RECEPTOR BLOCKERS IN PATIENTS WITH DIABETES IN JORDAN.
    Mayyas F; Bataineh W; Jarab A
    Endocr Pract; 2017 Nov; 23(11):1289-1296. PubMed ID: 28816537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of an intervention on the prescription of aliskiren after new evidence on safety reported.
    Rosich Martí I; Allepuz A; Rodriguez Palomar G; Ortin Font F; Soler Cera M
    Pharmacoepidemiol Drug Saf; 2017 Jan; 26(1):91-96. PubMed ID: 27859873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying adherent patients to newly initiated statins using previous adherence to chronic medications.
    Majd Z; Mohan A; Paranjpe R; Abughosh SM
    J Manag Care Spec Pharm; 2021 Feb; 27(2):186-197. PubMed ID: 33506725
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on end stage renal disease and major adverse cardiovascular events in diabetic patients: a population-based dynamic cohort study in Taiwan.
    Wu LS; Chang SH; Chang GJ; Liu JR; Chan YH; Lee HF; Wen MS; Chen WJ; Yeh YH; Kuo CT; See LC
    Cardiovasc Diabetol; 2016 Apr; 15():56. PubMed ID: 27039185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between Medication Adherence and Cardiovascular Disease Risk Factor Control in Elderly Patients with Diabetes.
    Raebel MA; Dyer W; Nichols GA; Goodrich GK; Schmittdiel JA
    Pharmacotherapy; 2017 Oct; 37(10):1204-1214. PubMed ID: 28752555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A physician targeted intervention improves prescribing in chronic heart failure in general medical units.
    Chua CC; Hutchinson A; Tacey M; Parikh S; Lim WK; Aboltins C
    BMC Health Serv Res; 2018 Mar; 18(1):206. PubMed ID: 29566753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers associated with lower risk of COVID-19 in household contacts.
    Armstrong K; Soltoff A; Rieu-Werden M; Metlay J; Haas J
    PLoS One; 2021; 16(3):e0247548. PubMed ID: 33651840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renin-angiotensin system blockers and residual kidney function loss in patients initiating peritoneal dialysis: an observational cohort study.
    Shen JI; Saxena AB; Vangala S; Dhaliwal SK; Winkelmayer WC
    BMC Nephrol; 2017 Jun; 18(1):196. PubMed ID: 28623899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do ACE Inhibitors/Angiotensin II type 1 receptor antagonists reduce hospitalisations in older patients with heart failure? A propensity analysis.
    Trewet CB; Shireman TI; Rigler SK; Howard PA
    Drugs Aging; 2007; 24(11):945-55. PubMed ID: 17953461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.